Paul Muller

Paul Muller is a Senior Scientist at Kallyope, where since February 2020, Paul has led drug discovery projects focused on pain and gastrointestinal diseases. Prior to this role, Paul served as a Scientist II Group Leader in the Enteric Nervous System Platform, developing platforms to enhance understanding of the gut nervous system's role in health and disease, and led a project team for an IBS-D target now in pre-clinical development. Paul's previous experience includes leadership roles and research positions at Grey Healthcare Group, Mount Sinai Medical Center, and Children's Hospital Boston. Paul holds a PhD in Gastrointestinal Neuroimmunology from The Rockefeller University and a PhD in Neuroimmunology from NYU School of Medicine, complemented by a B.S. in Biochemistry from Stony Brook University.